Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.731
Delayed Data
As of Apr 24
 -0.0132 / -1.77%
Today’s Change
0.65
Today|||52-Week Range
1.06
+4.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization9.0K9.6K3.7K5.9K
 
 
 
 
 
 
Operating ExpensesGross Income-9.0K-9.6K-3.7K-5.9K
 
 
 
 
 
General Expenses2.8M3.5M3.1M3.9M
 
 
 
 
 
Research And Development1.3M1.7M1.8M2.2M
 
 
 
 
 
Total Operating Expenses2.8M3.5M3.1M3.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.8M-3.5M-3.1M-3.9M
 
 
 
 
 
Extraordinary Credit0.003.7M1.2M1.6M
 
 
 
 
Extraordinary Charge-11.7M0.000.000.00
 
 
Other Expenses-206.2K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-14.6M194.5K-1.9M-2.2M
 
 
 
 
 
Net Income-14.6M194.5K-1.9M-2.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS170.1M177.7M178.2M178.3M
 
 
 
 
 
Shares To Calculate EPS Diluted170.1M177.7M178.2M178.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.09$0.00-$0.01-$0.01
 
 
 
 
EPS Diluted-$0.09$0.00-$0.01-$0.01
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account